Cargando…
Silencing of suppressor of cytokine signaling 1 enhances the immunological effect of mucin 1-calreticulin-primed 4T1 cell-treated dendritic cells in breast cancer treatment
In cancer immunotherapy, dendritic cell (DC)-based vaccines represent a promising, yet challenging, treatment method. In addition to overcoming the low expression levels of antigenic epitopes on cancer cells, it is also necessary to overcome the inhibitory effect of suppressor of cytokine signaling...
Autores principales: | Qin, Song, Gao, Zhipeng, Liu, Yu, Liu, Changbai, Wang, Jun, Zou, Li Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774391/ https://www.ncbi.nlm.nih.gov/pubmed/29434859 http://dx.doi.org/10.3892/ol.2017.7477 |
Ejemplares similares
-
Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro
por: Shi, Dongmei, et al.
Publicado: (2014) -
Immunological Activity Difference between Native Calreticulin Monomers and Oligomers
por: He, Mi-chun, et al.
Publicado: (2014) -
Self-Oligomerization Is Essential for Enhanced Immunological Activities of Soluble Recombinant Calreticulin
por: Huang, Shang-Hui, et al.
Publicado: (2013) -
PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
por: Yashiro, Takuya, et al.
Publicado: (2015) -
SjCRT, a recombinant Schistosoma japonicum calreticulin, induces maturation of dendritic cells and a Th1-polarized immune response in mice
por: Ma, Lizhen, et al.
Publicado: (2017)